Tag: firehawk

Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet

Coronary/Structural Heart by 0 comments

SHANGHAI, Sept. 3, 2018 /PRNewswire/ — MicroPort Scientific Corporation (“MicroPort®”, HK:0853) announced today that the clinical trial results for its Firehawk® Rapamycin Target Eluting Coronary Stent System (“Firehawk®”) which conducted a multi-center, randomized controlled trial called TARGET AC has been published online in […]

Continue Reading →

MicroPort(TM)’s Firehawk(TM) Drug Eluting Stent Achieves Primary Endpoint and Shows Very Promising Results From TARGET All-Comers Clinical Trial

Coronary/Structural Heart by 0 comments

PARIS, May 23, 2018 /PRNewswire/ — Today MicroPort Scientific Corporation (HKSE: 0853) (“MicroPort™”) announced primary endpoint data at 12 months and QCA angiography data at 13 months from its TARGET All-Comers (TARGET AC) trial. The results of the TARGET AC trial demonstrated […]

Continue Reading →